BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

We are very excited to officially welcome our PPD colleagues to Thermo Fisher Scientific," said Marc N. Casper, chairman, president and chief executiv...

December 09, 2021 | News

BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease

- Acquisition marks BD's entry point to the treatment of Chronic Venous Insufficiency -- adding transformative solutions to its existing venous disease por...

December 03, 2021 | News

Novavax Files COVID-19 Vaccine for EU Listing with WHO

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

November 05, 2021 | News

New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA

The TCI in Taiwan announced that its "Banana Peel, Banana Stamen" has received the FDA's new dietary supplement ingredient NDI safety response, a...

November 02, 2021 | News

Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers

Solution enables manufacturers to optimize manufacturing capacity, quality, efficiency and scalability 3M Separation and Purification Sciences announ...

November 01, 2021 | News

Why is the WHO delaying an EUL status to Covaxin?

The World Health Organisation usually takes around 6 to 9 weeks to analyse the data submitted by a vaccine manufacturer and then takes a call on whether to...

October 30, 2021 | Opinion | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."

Abcam Completes $340m strategic acquisition of BioVision

Abcam , a global innovator in life sciences reagents and tools, today announces the successful completion of its acquisition of BioVision and the expa...

October 28, 2021 | News

Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®

Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...

October 26, 2021 | News

QIAGEN launches novel QIAreach QuantiFERON-TB tuberculosis test for high-burden regions

QIAGEN leverages QuantiFERON®-TB technology to advance global efforts against TB TB IGRA testing now accessible in high burden, low resource and dec...

October 21, 2021 | News

Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes

$1,000,000,000 aggregate principal amount of its 18-month floating rate senior notes due 2023 (the "18-Month Floating Rate Notes"), $500,000,000&nb...

October 20, 2021 | News

Phillips-Medisize Increases Global Manufacturing Capacity

Medical and pharmaceutical solutions leader poised to scale manufacturing from new and expanded production facilities and R&D centers in Poland,&n...

October 20, 2021 | News

Merck and Eisai Receive Positive EU CHMP Opinions

Positive Opinion Granted for Advanced Renal Cell Carcinoma Based on Significant Progression-Free Survival (PFS), Overall Survival (OS) and Objective Respon...

October 18, 2021 | News

More than 50 companies modernize pharmacovigilance with Veeva Vault Safety Suite

Veeva Systems (NYSE: VEEV) today announced that more than 50 organizations are using Veeva Vault Safety Suite applications to sim...

October 14, 2021 | News

Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment ...

October 13, 2021 | News

Stay Connected